- Clinical Studies in Eastern BRIC countries
6 December 2011 / Ørestad / Denmark
MVA and Pharmacosmos CRO invited to a seminar on the challenges of selecting the right partners for clinical development in the East. The focus of this seminar was on China and India.
Venue: Main Auditorium, Edvard Thomsenvej 14, Ørestad
Date & Time: 6 December 2011, 09:00 - 13:30
(Please note that a Boost-seminar with a similar agenda was held 5 December 2011 in Lund - for further information click here)
Price
MVA members: Free of charge
Non-members: DKK 500 ex. VAT (registration is binding)
Program
|
09.00-09.30 |
Breakfast and registration |
|
09.30-09.40 |
Introduction |
|
|
MVA and Jeppe Skytte, Sales and Business Development, Pharmacosmos CRO A/S |
|
09.40-10.00 |
Market Potential in India |
|
|
Uffe Elleman-Jensen, former Minister for Foreign Affairs |
|
10.00-10.45 |
China: Market Access and Clinical Development in China |
|
|
Steen Krøyer and Betty Su, RXB Management Consulting |
|
10.45-11.05 |
China: The Ideal Way to the Chinese Market - Case based on actual experience with a number of companies |
|
|
Steen Krøyer and Betty Su, RXB Management Consulting |
|
11.05-11.20 |
Break |
|
11.20-11.50 |
India: Getting to the Market in India |
|
|
Renu Razdan, Chief Operating Officer, Max Neeman International |
|
11.50-12.30 |
India: Clinical Development in India |
|
|
Renu Razdan, Chief Operating Officer, Max Neeman International |
|
12.30-12.45 |
The Reason We Chose Asia - What did we do |
|
|
Lars Lykke Thomsen, Vice President Chief Medical Officer, Pharmacosmos A/S |
|
12.45-13.00 |
Panel discussion hosted by Pharmacosmos CRO |
|
13.00- |
Lunch |
MVA and Pharmacosmos CRO invites all participant to a light lunch.
Pharmacosmos CRO offers unique access to optimized global medical product development for European biotech and pharmaceutical companies.